Manulife (Manufacturers Life Insurance)
THRX

Manulife (Manufacturers Life Insurance)’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-79,751
Closed -$215K – 3039
2023
Q3 		$215K Sell
79,751
-8,130
-9% -$31.9K ﹤0.01% 2561
2023
Q2 		$820K Buy
87,881
+8,130
+10% +$80.1K ﹤0.01% 1764
2023
Q1 		$708K Buy
79,751
+23,683
+42% +$232K ﹤0.01% 1794
2022
Q4 		$284K Buy
56,068
+185
+0.3% +$1.08K ﹤0.01% 2344
2022
Q3 		$341K Hold
55,883
– – ﹤0.01% 2219
2022
Q2 		$291K Sell
55,883
-4,040
-7% -$33.4K ﹤0.01% 2418
2022
Q1 		$701K Buy
+59,923
New +$641K ﹤0.01% 1968

Other funds holding THRX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $508M AUM 163.77% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s THRX Position: Q4 2023 in Review

Manulife (Manufacturers Life Insurance) sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q4 2023, closing a stake of 79,751 shares — an estimated $215K sold.

Manulife (Manufacturers Life Insurance) first reported a position in THRX in Q1 2022 and held it in 7 quarters. The position peaked at $820K in Q2 2023. 70 funds tracked by Wall St. Rank hold THRX as of Q4 2023.

  • Manulife (Manufacturers Life Insurance) reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 79,751 Theseus Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $215K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Manulife (Manufacturers Life Insurance)'s Theseus Pharmaceuticals, Inc. Common Stock position peaked at $820K in Q2 2023.
  • 70 funds tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2023, filed 13 Feb 2024.